Opin vísindi
Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018
- Opin vísindi
- →
- IRIS
- →
- IRIS
- →
- Skoða verk
JavaScript is disabled for your browser. Some features of this site may not work without it.
| Titill: | Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018 |
| Höfundur: | |
| Útgáfa: | 2019-11-14 |
| Tungumál: | Enska |
| Umfang: | 292741 |
| Háskóli/Stofnun: | Landspitali - The National University Hospital of Iceland |
| Deild: | Faculty of Medicine Clinical Laboratory Services, Diagnostics and Blood Bank |
| Birtist í: | Eurosurveillance; 24(46) |
| ISSN: | 1025-496X |
| DOI: | 10.2807/1560-7917.ES.2019.24.46.1900656 |
| Efnisorð: | Epidemiology; Public Health, Environmental and Occupational Health; Virology |
| URI: | https://hdl.handle.net/20.500.11815/3499 |
Tilvitnun:ESAC-Net study group, EARS-Net study group 2019 , ' Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018 ' , Eurosurveillance , vol. 24 , no. 46 , 1900656 . https://doi.org/10.2807/1560-7917.ES.2019.24.46.1900656
|
|
Útdráttur:Investments to reduce the spread of antimicrobial resistance (AMR) in the European Union have been made, including efforts to strengthen prudent antimicrobial use. Using segmented regression, we report decreasing and stabilising trends in data reported to the European Surveillance of Antimicrobial Consumption Network and stabilising trends in data reported to the European Antimicrobial Resistance Surveillance Network. Our results could be an early indication of the effect of prioritising AMR on the public health agenda.
|
|
Athugasemdir:The authors acknowledge the work performed by the staff of the participating clinical microbiology laboratories and of the national healthcare services that provided data to ESAC-Net and EARS-Net.
Germán Peñalva was supported by El Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2013‐2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001) ‐ co‐financed by European Development Regional Fund “A way to achieve Europe”, Operative program Intelligent Growth 2014‐2020, and received a grant from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for a three-month study visit at ECDC during which the analysis was performed. Publisher Copyright: © 2019 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
|
|
